Now showing items 1-1 of 1
A qualitative and quantitative evaluation of amantadine in the treatment of Parkinson's disease
(Elsevier, 1972-03)
A double-blind crossover trial of amantadine vs. placebo was carried out involving 42 patients with Parkinson's disease: 64 per cent of the patients on amantadine experienced subjective improvement compared to 21 per cent ...